Sample Applications & More
Check out our many sample applications and summary statements. Below the list of applications, you’ll also find NIAID and NIH example forms, sharing plans, letters, emails, and more.
Table of Contents
- R01 Sample Applications and Summary Statements
- R03 Sample Applications and Summary Statements
- R21 Sample Applications and Summary Statements
- R21/R33 Sample Application and Summary Statement
- R41, R42, R43, and R44 Sample Applications
- F31-Diversity Sample Applications and Summary Statements
- NIAID and NIH Sample Forms, Plans, Letters, Emails, and More
Sample Applications
Several investigators have graciously agreed to let us post their exceptional applications online.
We are truly indebted to the investigators listed below, who have enabled us to deliver this widely anticipated resource to the research community.
We selected these applications as sound examples of good grantsmanship. That said, time has passed since these grantees applied, and so the samples may not reflect the latest application format or rules. Therefore, always follow your funding opportunity's instructions for application format. We post new samples periodically.
Note: The text of these applications is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited.
R01 Sample Applications and Summary Statements
| PI and Grantee Institution | Application Resources |
|---|---|
|
William Faubion, Ph.D., of the Mayo Clinic Rochester |
|
|
Chengwen Li, Ph.D., and Richard Samulski, Ph.D., of University of North Carolina at Chapel Hill |
|
|
Mengxi Jiang, Ph.D., of University of Alabama at Birmingham |
R03 Sample Applications and Summary Statements
The small grant (R03) supports new research projects that can be carried out in a short period of time with limited resources. They are awarded for up to two years and are not renewable. R03s are not intended for new investigators.
| PI and Grantee Institution | Application Resources |
|---|---|
|
Martin Karplus, Ph.D., of Harvard University |
|
|
Chad A. Rappleye, Ph.D., of Ohio State University |
R21 Sample Applications and Summary Statements
Please note that the R21 funds novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. R21s are not intended for new investigators, and there is no evidence that they provide a path to an independent research career.
| PI and Grantee Institution | Application Resources |
|---|---|
|
Steven W. Dow, DVM, Ph.D., of Colorado State University, Fort Collins |
|
|
Joseph M. McCune, MD, Ph.D., of the University of California, San Francisco |
|
|
Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., of the Seattle Biomedical Research Institute |
|
|
Howard T. Petrie, of Scripps Florida |
|
|
Michael N. Starnbach, Ph.D., of Harvard University Medical School |
R21/R33 Sample Application and Summary Statement
The R21/R33 supports a two-phased award without a break in funding. It begins with the R21 phase for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition to the second phase depends on several factors, including the achievement of negotiated milestones.
| PI and Grantee Institution | Application Resources |
|---|---|
|
Stephen Dewhurst, Ph.D., of the University of Rochester |
R41, R42, R43, and R44 Sample Applications
The SBIR (R43/R44) and STTR (R41/R42) programs support domestic small businesses to engage in research and development with the potential for commercialization.
| PI and Grantee Institution | Application Resources |
|---|---|
|
Raymond Houghton, InBios International, and David AuCoin, University of Nevada School of Medicine |
|
|
Mark Poritz* of BioFire Diagnostics, LLC. |
|
|
Timothy C. Fong of Cellerant Therapeutics, Inc. |
|
|
Jose M. Galarza of Technovax, Inc. |
|
|
Patricia Garrett of Immunetics, Inc. |
|
|
Michael J. Lochhead of MBio Diagnostics, Inc. |
|
|
Kenneth Coleman of Arietis Corporation |
*Dr. Mark Poritz submitted the original grant application. In the course of the first year of funding, Dr. Andrew Hemmert took on increasing responsibility for the work. For the grant renewal, Dr. Poritz proposed that Dr. Hemmert replace him as the PI.
F31-Diversity Sample Applications and Summary Statements
The F31-Diversity supports predoctoral students from underrepresented racial and ethnic groups, those with disabilities, and those from disadvantaged backgrounds. It also provides individualized, mentored research training from outstanding faculty sponsors.
| PI and Grantee Institution | Application Resources |
|---|---|
|
Adjoa R. Smalls-Mantey of Columbia University Health Sciences |
|
|
Juan Calix of University of Alabama at Birmingham |
NIAID and NIH Sample Forms, Plans, Letters, Emails, and More
NIAID
- Sample Data Sharing Plan
- Sample Model Organism Sharing Plans
- Sample Letter to Document Training in the Protection of Human Subjects
- Withdrawal of an Application Sample Form Letter
- Just-in-Time
- International Grants
- Preparing for a Foreign Organization System (FOS) Review
- Subaward Agreement Forms from the Federal Demonstration Partnership
- DMID Quality Management Guidance and Tools
NIH
- Annotated SF 424 Grant Application Forms
- Examples of Project Leadership Plans for Multiple PI Grant Applications
- Example calculations in the Usage of Person Months questions and answers
- SF 424 Application Guide's Additional Format Pages
- OLAW's Sample Documents for animal research assurances and reports
Have Questions?
A program officer in your area of science can give you application advice, NIAID's perspective on your research, and confirmation that NIAID will accept your application.
Find contacts and instructions at When to Contact a NIAID Program Officer.